Russell Investments Group
CYCN icon

Russell Investments Group’s Cyclerion Therapeutics CYCN Stock Holding History

Russell Investments Group’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,204
Closed -$345K – 3226
2021
Q1 		$345K Buy
6,204
+4,964
+400% +$373K ﹤0.01% 2665
2020
Q4 		$75K Sell
1,240
-1,338
-52% -$91.2K ﹤0.01% 2888
2020
Q3 		$312K Buy
2,578
+1,190
+86% +$136K ﹤0.01% 2598
2020
Q2 		$163K Buy
1,388
+178
+15% +$14.9K ﹤0.01% 2772
2020
Q1 		$63K Hold
1,210
– – ﹤0.01% 2839
2019
Q4 		$64K Sell
1,210
-3,365
-74% -$314K ﹤0.01% 2962
2019
Q3 		$1.11M Buy
+4,575
New +$988K ﹤0.01% 1953

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Russell Investments Group's CYCN Position: Q2 2021 in Review

Russell Investments Group sold out of Cyclerion Therapeutics (CYCN) in Q2 2021, closing a stake of 6,204 shares — an estimated $345K sold.

Russell Investments Group first reported a position in CYCN in Q3 2019 and held it in 7 quarters. The position peaked at $1.11M in Q3 2019. 67 funds tracked by Wall St. Rank hold CYCN as of Q2 2021.

  • Russell Investments Group reported no remaining Cyclerion Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Russell Investments Group sold 6,204 Cyclerion Therapeutics shares in Q2 2021, an estimated $345K.
  • Russell Investments Group first reported a position in Cyclerion Therapeutics in Q3 2019 and held it in 7 quarters.
  • Russell Investments Group's Cyclerion Therapeutics position peaked at $1.11M in Q3 2019.
  • 67 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.